Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, $.01 par value
-
Shares outstanding
-
4.41M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
692K
-
Shares change
-
+143K
-
Total reported value, excl. options
-
$2.14M
-
Value change
-
-$112K
-
Number of buys
-
10
-
Number of sells
-
-5
-
Price
-
$3.09
Significant Holders of INTERPACE BIOSCIENCES, INC. - Common Stock, $.01 par value (IDXG) as of Q3 2020
19 filings reported holding IDXG - INTERPACE BIOSCIENCES, INC. - Common Stock, $.01 par value as of Q3 2020.
INTERPACE BIOSCIENCES, INC. - Common Stock, $.01 par value (IDXG) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 692K shares
of 4.41M outstanding shares and own 15.7% of the company stock.
Largest 10 shareholders include Stonepine Capital Management, LLC (285K shares), BlackRock Inc. (117K shares), Penbrook Management LLC (84.4K shares), VANGUARD GROUP INC (69K shares), Magnus Financial Group LLC (48.5K shares), GEODE CAPITAL MANAGEMENT, LLC (32.5K shares), Squarepoint Ops LLC (25.2K shares), DIMENSIONAL FUND ADVISORS LP (12.9K shares), CITADEL ADVISORS LLC (11.9K shares), and UBS Group AG (3.47K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.